NTV Asset Management LLC Purchases New Position in ARK Genomic Revolution ETF $ARKG

NTV Asset Management LLC purchased a new position in ARK Genomic Revolution ETF (BATS:ARKG) in the third quarter, HoldingsChannel reports. The fund purchased 160,196 shares of the company’s stock, valued at approximately $4,449,000.

Several other institutional investors and hedge funds have also bought and sold shares of ARKG. ARK Investment Management LLC boosted its position in ARK Genomic Revolution ETF by 11.0% during the 2nd quarter. ARK Investment Management LLC now owns 4,321 shares of the company’s stock valued at $105,000 after acquiring an additional 429 shares in the last quarter. Dynamic Advisor Solutions LLC lifted its stake in shares of ARK Genomic Revolution ETF by 4.3% in the 3rd quarter. Dynamic Advisor Solutions LLC now owns 11,000 shares of the company’s stock valued at $305,000 after purchasing an additional 453 shares during the period. Private Wealth Asset Management LLC boosted its position in shares of ARK Genomic Revolution ETF by 70.0% during the second quarter. Private Wealth Asset Management LLC now owns 1,275 shares of the company’s stock valued at $31,000 after purchasing an additional 525 shares in the last quarter. Wealthcare Advisory Partners LLC grew its stake in ARK Genomic Revolution ETF by 3.9% in the second quarter. Wealthcare Advisory Partners LLC now owns 15,678 shares of the company’s stock worth $382,000 after purchasing an additional 590 shares during the period. Finally, Atlantic Union Bankshares Corp purchased a new stake in ARK Genomic Revolution ETF in the second quarter worth $34,000.

ARK Genomic Revolution ETF Trading Up 23.7%

ARKG opened at $29.20 on Friday. The stock has a fifty day simple moving average of $29.60 and a two-hundred day simple moving average of $27.42. ARK Genomic Revolution ETF has a 12-month low of $17.51 and a 12-month high of $31.16.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.